Table of Contents Author Guidelines Submit a Manuscript
Canadian Journal of Gastroenterology and Hepatology
Volume 2016, Article ID 9513742, 4 pages
http://dx.doi.org/10.1155/2016/9513742
Editorial

Management of Inflammatory Bowel Disease in Pregnancy: A Practical Approach to New Guidelines

1Department of Medicine, University of Alberta, Edmonton, AB, Canada T6G 2X8
2Department of Medicine, University of Calgary, Calgary, AB, Canada T2N 4Z6
3Mount Sinai Hospital Centre for Inflammatory Bowel Disease, University of Toronto, Toronto, ON, Canada M5G 1X5
4Department of Community Health Sciences, University of Calgary, Calgary, AB, Canada T2N 4Z6

Received 28 March 2016; Accepted 4 April 2016

Copyright © 2016 V. Huang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. Cornish, E. Tan, J. Teare et al., “A meta-analysis on the influence of inflammatory bowel disease on pregnancy,” Gut, vol. 56, no. 6, pp. 830–837, 2007. View at Publisher · View at Google Scholar · View at Scopus
  2. R. Mountifield, P. Bampton, R. Prosser, K. Muller, and J. M. Andrews, “Fear and fertility in inflammatory bowel disease: a mismatch of perception and reality affects family planning decisions,” Inflammatory Bowel Diseases, vol. 15, no. 5, pp. 720–725, 2009. View at Publisher · View at Google Scholar · View at Scopus
  3. R. E. Mountifield, R. Prosser, P. Bampton, K. Muller, and J. M. Andrews, “Pregnancy and IBD treatment: this challenging interplay from a patients' perspective,” Journal of Crohn's and Colitis, vol. 4, no. 2, pp. 176–182, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. C. P. Selinger, J. Eaden, W. Selby et al., “Inflammatory bowel disease and pregnancy: lack of knowledge is associated with negative views,” Journal of Crohn's and Colitis, vol. 7, no. 6, pp. e206–e213, 2013. View at Publisher · View at Google Scholar · View at Scopus
  5. M. Tan, R. H. Holloway, K. Lange, and J. M. Andrews, “General practitioners' knowledge of and attitudes to inflammatory bowel disease,” Internal Medicine Journal, vol. 42, no. 7, pp. 801–807, 2012. View at Publisher · View at Google Scholar · View at Scopus
  6. D. Toomey and B. Waldron, “Family planning and inflammatory bowel disease: the patient and the practitioner,” Family Practice, vol. 30, no. 1, pp. 64–68, 2013. View at Publisher · View at Google Scholar · View at Scopus
  7. Z. Zelinkova, P. B. Mensink, J. Dees, E. J. Kuipers, and C. J. Van Der Woude, “Reproductive wish represents an important factor influencing therapeutic strategy in inflammatory bowel diseases,” Scandinavian Journal of Gastroenterology, vol. 45, no. 1, pp. 46–50, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. I. Blumenstein, E. Herrmann, N. Filmann et al., “Female patients suffering from inflammatory bowel diseases are treated less frequently with immunosuppressive medication and have a higher disease activity. A subgroup analysis of a large multi-centre, prospective, internet-based study,” Journal of Crohn's and Colitis, vol. 5, no. 3, pp. 203–210, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. L. Peyrin-Biroulet, A. Oussalah, X. Roblin, and M. P. Sparrow, “The use of azathioprine in Crohn's disease during pregnancy and in the post-operative setting: a worldwide survey of experts,” Alimentary Pharmacology & Therapeutics, vol. 33, no. 6, pp. 707–713, 2011. View at Publisher · View at Google Scholar · View at Scopus
  10. V. Huang, K. I. Kroeker, K. Goodman, K. Hegadoren, L. A. Dieleman, and R. N. Fedorak, “Physician knowledge of reproductive issues in inflammatory bowel disease is highly variable,” Journal of Crohn's and Colitis, vol. 7, supplement 1, pp. S173–S174, 2013. View at Google Scholar
  11. G. C. Nguyen, C. H. Seow, C. Maxwell et al., “The Toronto consensus statements for the management of inflammatory bowel disease in pregnancy,” Gastroenterology, vol. 150, no. 3, pp. 734–757.e1, 2016. View at Publisher · View at Google Scholar
  12. C. J. van der Woude, S. Ardizzone, M. B. Bengtson et al., “The second European evidenced-based consensus on reproduction and pregnancy in inflammatory bowel disease,” Journal of Crohn's & Colitis, vol. 9, no. 2, pp. 107–124, 2015. View at Publisher · View at Google Scholar · View at Scopus
  13. U. Mahadevan, D. C. Wolf, M. Dubinsky et al., “Placental transfer of anti-tumor necrosis factor agents in pregnant patients with inflammatory bowel disease,” Clinical Gastroenterology and Hepatology, vol. 11, no. 3, pp. 286–292, 2013. View at Publisher · View at Google Scholar · View at Scopus
  14. Z. Zelinkova, C. van der Ent, K. F. Bruin et al., “Effects of discontinuing anti-tumor necrosis factor therapy during pregnancy on the course of inflammatory bowel disease and neonatal exposure,” Clinical Gastroenterology and Hepatology, vol. 11, no. 3, pp. 318–321, 2013. View at Publisher · View at Google Scholar · View at Scopus
  15. J. Torres, R. K. Boyapati, N. A. Kennedy, E. Louis, J.-F. Colombel, and J. Satsangi, “Systematic review of effects of withdrawal of immunomodulators or biologic agents from patients with inflammatory bowel disease,” Gastroenterology, vol. 149, no. 7, pp. 1716–1730, 2015. View at Publisher · View at Google Scholar · View at Scopus